Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials

Published:2020-10 Issue: Volume:194 Page:57-65
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Haykal Tarek^ORCID,Zayed Yazan,Deliwala Smit^ORCID,Kerbage Josiane,Ponnapalli Anoosha,Malladi Srikanth,Goranta Sowmya,Samji Varun,Adam Soheir^ORCID

Publisher

Elsevier BV

Subject

Hematology

Reference32 articles.

1. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer: a population-based cohort study;Cohen;Thromb Haemost,2017

2. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis;Horsted;PLoS Med,2012

3. Epidemiology of cancer-associated venous thrombosis;Timp;Blood,2013

4. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood,2002

5. 2019 International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer;Farge;Lancet Oncol,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating cancer-associated venous thromboembolism: A practical approach;European Journal of Cancer;2024-09

2. The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts;Journal of Blood Medicine;2024-04

3. Direct Oral Anticoagulants in Thromboembolism in Patients with Solid Cancer: Can They Be Privileged?;International Journal of Pharmacology;2024-03-15

4. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis;World Journal of Surgical Oncology;2024-02-26

5. Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis;Surgical Endoscopy;2024-01-24